Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
21st Annual Meeting of the Consortium of Multiple Sclerosis Centers
New Directions in Pain Management for Patients with Multiple Sclerosis
Washington, DC / May 30-June 2, 2007
Washington, DC - Multiple sclerosis (MS) is a debilitating disease of the central nervous system and is the most common neurological disease affecting young adults in Canada today. An estimated 50,000 Canadian men and women currently have...
2007 Annual Conference of the Canadian Pain Society
Addressing the Triad of Pain, Psychological Symptoms and Sleep Disturbance
Ottawa, Ontario / May 23-26, 2007
Ottawa - Chronic pain is associated with significant distress and may be accompanied by sleep disturbance and/or psychological symptoms such as depression and anxiety. Concurrent treatment of comorbidities is a crucial element of...
59th Annual Meeting of the American Academy of Neurology
Clinically Isolated Syndrome in Multiple Sclerosis: Corroborative Evidence for Early Treatment
Boston, Massachusetts / April 29-May 5, 2007
Boston - About 85% of patients who develop multiple sclerosis (MS) have a clinically isolated syndrome (CIS) as the first manifestation of the disease, and 88% of people who have CIS eventually develop MS. Evidence from several trials shows...
59th Annual Meeting of the American Academy of Neurology
Emerging Strategies to Enhance Clinical Efficacy of Current Treatments for Multiple Sclerosis
Boston, Massachusetts / April 28-May 5, 2007
Boston - Novel strategies in which current therapies for relapsing-remitting multiple sclerosis (RRMS), used sequentially or in combination with immunosuppressive agents, have demonstrated synergy in their effect on disease activity...
59th Annual Meeting of the American Academy of Neurology
Developments in the Treatment of Acute Intracerebral Hemorrhage
Boston, Massachusetts / April 28-May 5, 2007
Boston - Two clinical trials of hemostatic therapy using recombinant factor VIIa (rFVIIa) have been conducted in patients with intracerebral hemorrhage (ICH). A phase IIb trial reported previously demonstrated that rFVIIa in patients with...
70th Annual Meeting of the American College of Rheumatology
Emerging Options in Fibromyalgia
Washington, DC / November 10-15, 2006
The syndrome of fibromyalgia is characterized by widespread musculoskeletal pain, disturbed sleep and fatigue. The etiology and pathophysiology of fibromyalgia remain incompletely understood, although the symptoms have been associated with...
International Stroke Society-Joint World Congress on Stroke
New Developments in the Management of Intracerebral Hemorrhage
Cape Town, South Africa / October 26-29, 2006
Cape Town - Intracerebral hemorrhage is the stroke type with the worst prognosis and mortality rate of over 50%. Historically, clinicians have little other than stroke unit care to offer these patients. A recent study of recombinant factor...
Canadian Cardiovascular Congress 2006
Reducing Stroke Through RAS Inhibition: Benefits and Mechanisms
Vancouver, British Columbia / October 21-25, 2006
Vancouver - The control of hypertension has a well-established positive impact on the risk of stroke. Whether one or more antihypertensive agents may be particularly beneficial for reducing stroke incidence is unclear. As discussed here...
22nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Maximizing the Benefits of Multiple Sclerosis Therapy in Clinically Isolated Syndrome
Madrid, Spain / September 27-30, 2006
Madrid - Early treatment of multiple sclerosis (MS) consists of starting therapy in patients presenting with a first clinical event suggestive of MS by means of a clinically isolated syndrome. The rationale rests on two key considerations:...